Insiders bought dividend stocks like Lakeland Industries, York Water, and RLI Corp. in January and indicate higher share price could be coming in 2025.
AbbVie is on track to sustain growth in the wake of Humira's patent cliff and the forecasts are too low. Investors can look forward to an upgrade cycle in 2025.
Microsoft's Q2 results hint at the robust outlook for AI services industry growth, expected to sustain a 36% CAGR through the middle of the next decade.
Procter & Gamble is a solid blue-chip dividend growth stock on track to increase its distribution in 2025 by mid-single-digits, and its shares are rising.
Oracle had a game-changing year, establishing itself as a leading player in AI infrastructure and services. The growth and dividend outlook is improving.
J.B. Hunt leads truckers lower in January, but they won't stay down long. The freight industry is set to rebound in 2025 and support capital return growth.
UnitedHealth Group pulls back from a peak to open a healthy opportunity for long-term investors. Secular trends support the company and which pays to own it.
The FOMC is likelier to hike than cut rates in 2025 because the inflation trend is sideways, labor markets are healthy, and inflationary pressures are building.
NVIDIA is to AI as Google is to the Internet, only more so; new advances cement its leadership position and point to a $5 trillion market cap within two years.
AI is gaining traction, as are these alternatives to NVIDIA and the hyperscalers. Ambarella, Palantir, and AeroVironment monetize AI today and business grows.
Legacy software technology is fading fast as AI sweeps the globe; these legacy tech companies are shifting with the winds and emerging as AI industry leaders.
Insider trades are a telling indicator of C-Suite conviction but aren't always the signal for investors they could be. Only two of these stocks are good buys.